Michael T. Lotze

Peritumoral CD1a-Positive Dendritic Cells Are Associated With Improved Survival in Patients With Tongue Carcinoma

Steven A. Goldman, Evan Baker, Robert J. Weyant et al. · Archives of Otolaryngology - Head and Neck Surgery · 1998 · 120 citations

Medicine, Oncology, Oral Pathology +13

Genetically modified bone marrow‐derived dendritic cells expressing tumor‐associated viral or “self” antigens induce antitumor immunity <i>in vivo</i>

Thomas Tüting, Albert B. DeLeo, Michael T. Lotze et al. · European Journal of Immunology · 1997 · 115 citations

Life Sciences, Immunology, Oncology +17

Development of Hepatocellular Carcinoma Among Patients with Chronic Liver Disease due to Hepatitis C Viral Infection

Adrian M. Di Bisceglie, Lisa H. Simpson, Michael T. Lotze et al. · Journal of Clinical Gastroenterology · 1994 · 86 citations

Medicine, Infectious Diseases, Oncology +17

Identification of wild‐type and mutant p53 peptides binding to HLA‐A2 assessed by a peptide loading‐deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay

György Stuber, Gerhard Leder, Walter J. Storkus et al. · European Journal of Immunology · 1994 · 73 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase II Trial of Systemic Recombinant Interleukin-2 in the Treatment of Refractory Nasopharyngeal Carcinoma

Kwan‐Hwa Chi, Jeffrey N. Myers, Kuan‐Chih Chow et al. · Oncology · 2001 · 31 citations

Medicine, Immunology, Oncology +17